82 related articles for article (PubMed ID: 8843228)
1. The use of cyclosporine, FK506, and SDZ NIM811 to prevent CD25- quiescent peripheral blood mononuclear cells from producing human immunodeficiency virus.
Borvak J; Chou CS; Van Dyke G; Rosenwirth B; Vitetta ES; Ramilo O
J Infect Dis; 1996 Oct; 174(4):850-3. PubMed ID: 8843228
[TBL] [Abstract][Full Text] [Related]
2. Combined use of an immunotoxin and cyclosporine to prevent both activated and quiescent peripheral blood T cells from producing type 1 human immunodeficiency virus.
Bell KD; Ramilo O; Vitetta ES
Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1411-5. PubMed ID: 8434001
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog.
Rosenwirth B; Billich A; Datema R; Donatsch P; Hammerschmid F; Harrison R; Hiestand P; Jaksche H; Mayer P; Peichl P
Antimicrob Agents Chemother; 1994 Aug; 38(8):1763-72. PubMed ID: 7527198
[TBL] [Abstract][Full Text] [Related]
4. The use of two immunosuppressive drugs, cyclosporin A and tacrolimus, to inhibit virus replication and apoptosis in cells infected with feline immunodeficiency virus.
Mortola E; Endo Y; Ohno K; Watari T; Tsujimoto H; Hasegawa A
Vet Res Commun; 1998 Dec; 22(8):553-63. PubMed ID: 10066129
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporine A inhibits in vitro replication of betaretrovirus associated with primary biliary cirrhosis.
Montano-Loza AJ; Wasilenko S; Bintner J; Mason AL
Liver Int; 2010 Jul; 30(6):871-7. PubMed ID: 20492501
[TBL] [Abstract][Full Text] [Related]
6. FK506 and cyclosporin A inhibit granulocyte/macrophage colony-stimulating factor production by mononuclear cells in asthma.
Sano T; Nakamura Y; Matsunaga Y; Takahashi T; Azuma M; Okano Y; Shimizu E; Ogushi F; Sone S; Ogura T
Eur Respir J; 1995 Sep; 8(9):1473-8. PubMed ID: 8575571
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK 506.
Karpas A; Lowdell M; Jacobson SK; Hill F
Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8351-5. PubMed ID: 1381509
[TBL] [Abstract][Full Text] [Related]
8. The in vitro immunosuppressive effect of deoxymethylspergualin in man as compared with FK506 and cyclosporine.
Takahara S; Jiang H; Takano Y; Kokado Y; Ishibashi M; Okuyama A; Sonoda T
Transplantation; 1992 Apr; 53(4):914-8. PubMed ID: 1373537
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of the immunosuppressant FK506 on apoptotic cell death induced by HIV-1 gp120.
Sekigawa I; Koshino K; Hishikawa T; Kaneko H; Takasaki Y; Hashimoto H; Hirose S; Inagaki Y; Yamamoto N
J Clin Immunol; 1995 Nov; 15(6):312-7. PubMed ID: 8576317
[TBL] [Abstract][Full Text] [Related]
10. FK506 suppresses neutrophil chemoattractant production by peripheral blood mononuclear cells.
Sasakawa Y; Sakuma S; Higashi Y; Sasakawa T; Amaya T; Goto T
Eur J Pharmacol; 2000 Sep; 403(3):281-8. PubMed ID: 10973631
[TBL] [Abstract][Full Text] [Related]
11. In vitro effects of cyclosporine A and tacrolimus on regulatory T-cell proliferation and function.
Miroux C; Morales O; Ghazal K; Othman SB; de Launoit Y; Pancré V; Conti F; Delhem N
Transplantation; 2012 Jul; 94(2):123-31. PubMed ID: 22743548
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of T lymphocyte activation and apoptotic cell death by cyclosporin A and tacrolimus (FK506). Its relevance to therapy of HIV infection.
Thomson AW; Bonham CA
Adv Exp Med Biol; 1995; 374():211-6. PubMed ID: 7572394
[TBL] [Abstract][Full Text] [Related]
13. The non-immunosuppressive cyclosporin A analogue SDZ NIM 811 inhibits cyclophilin A incorporation into virions and virus replication in human immunodeficiency virus type 1-infected primary and growth-arrested T cells.
Mlynar E; Bevec D; Billich A; Rosenwirth B; Steinkasserer A
J Gen Virol; 1997 Apr; 78 ( Pt 4)():825-35. PubMed ID: 9129655
[TBL] [Abstract][Full Text] [Related]
14. Tacrolimus and cyclosporine A inhibit human osteoclast formation via targeting the calcineurin-dependent NFAT pathway and an activation pathway for c-Jun or MITF in rheumatoid arthritis.
Miyazaki M; Fujikawa Y; Takita C; Tsumura H
Clin Rheumatol; 2007 Feb; 26(2):231-9. PubMed ID: 16586042
[TBL] [Abstract][Full Text] [Related]
15. Different effects of cyclosporine a and FK506 on potassium transport systems in MDCK cells.
Aker S; Heering P; Kinne-Saffran E; Deppe C; Grabensee B; Kinne RK
Exp Nephrol; 2001; 9(5):332-40. PubMed ID: 11549851
[TBL] [Abstract][Full Text] [Related]
16. FK506 potently inhibits T cell activation induced TNF-alpha and IL-1beta production in vitro by human peripheral blood mononuclear cells.
Sakuma S; Kato Y; Nishigaki F; Sasakawa T; Magari K; Miyata S; Ohkubo Y; Goto T
Br J Pharmacol; 2000 Aug; 130(7):1655-63. PubMed ID: 10928971
[TBL] [Abstract][Full Text] [Related]
17. The hydroxylamine of sulfamethoxazole synergizes with FK506 and cyclosporin A, inhibiting T-cell proliferation.
Hess DA; Bird IA; Almawi WY; Rieder MJ
J Pharmacol Exp Ther; 1997 Apr; 281(1):540-8. PubMed ID: 9103542
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin and FK506 differentially inhibit mast cell cytokine production and cytokine-induced proliferation and act as reciprocal antagonists.
Hatfield SM; Mynderse JS; Roehm NW
J Pharmacol Exp Ther; 1992 Jun; 261(3):970-6. PubMed ID: 1376361
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs.
Bocian K; Borysowski J; Wierzbicki P; Wyzgal J; Klosowska D; Bialoszewska A; Paczek L; Górski A; Korczak-Kowalska G
Nephrol Dial Transplant; 2010 Mar; 25(3):710-7. PubMed ID: 19903662
[TBL] [Abstract][Full Text] [Related]
20. Effect of immunosuppressive drugs on spontaneous DNA repair in human peripheral blood mononuclear cells.
Ori Y; Herman-Edelstein M; Zingerman B; Rozen-Zvi B; Gafter U; Malachi T; Gafter-Gvili A
Biomed Pharmacother; 2012 Sep; 66(6):409-13. PubMed ID: 22795807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
